NCT05250115Terminated
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
This is a Prospective, Single-arm, Multicenter, Observational Non-interventional Study (NIS) in Germany of Patient Characteristics, Usage, and Effectiveness of Abrocitinib in Patients With Moderate to Severe Atopic Dermatitis (AD)
Source: ClinicalTrials.gov · Last updated 29 Sept 2025
Reason given: Business decision: Due to the slow recruitment, the sponsor decided to discontinue the study early.
Brief summary (registry, in English)
The purpose of this non-interventional observational study is to learn about the safety and effects of the medicinal product (called Abrocitinib) for the potential treatment of moderate to severe atopic dermatitis (AD). AD is a long-lasting disease that causes redness and irritation of the skin. This non-interventional study is seeking participants who is eligible for Abrocitinib treatment according to the summary of product characteristics (SmPC): * Are aged at least 18 years old * Have a confirmed diagnosis of AD by a skin doctor * Decide to start treatment with Abrocitinib as part of routine clinical practice * Have a personally signed and dated informed consent document. This is used to indicate that the patient has been informed of all pertinent aspects of the study and data privacy aspects Participants will take the medicinal product as prescribed in the real-world setting. We will examine the experiences of people receiving Abrocitinib. This will help us determine if the medicinal product is effective and safe. Participants will take part in this study for 3 months. During this time, participants will be followed up from the date of their first Abrocitinib prescription for 12 months. During this non-interventional study, some participants may switch to other therapies after their initial Abrocitinib therapy. We will follow these participants further when they switch therapy to monitor their experiences. Participant documentation is expected quarterly as per standard clinical practice.
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 112 (actual)
- First submitted
- 10 Feb 2022
- Start date
- 10 May 2022
- Primary completion date
- 25 Jul 2024
- Lead sponsor
- Pfizer
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT05250115
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receipt of any investigational drug within 3 months or longer if required according to wash-out period prior to inclusion or participation in a clinical trial during observation period
- Patients being treated with abrocitinib within a time period of <28 days prior to the timepoint of study inclusion
Other
- Contraindications according to SmPC
- Patients who are investigational site staff members or patients who are Pfizer employees directly involved in the conduct of the non-interventional study
- Patients who are unable to consent
Who the study is looking for
- Patients aged ≥18 years
- Confirmed diagnosis of AD by dermatologist prior to study inclusion
- Patient for whom the decision to initiate treatment with abrocitinib was made as part of routine clinical practice irrespective of the patients being
- abrocitinib naive or,
- patients who reinitialize treatment with abrocitinib after being off treatment for ≥28 days prior to study inclusion
- Patient is eligible for abrocitinib treatment according to Summary of Product Characteristics (SmPC)
- Evidence of a personally signed and dated informed consent document indicating that the patient has been informed of all pertinent aspects of the non-interventional study
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (38)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hautärztliche Gemeinschaftspraxis | Ahaus | Germany | Unknown status |
| Hautarztpraxis Dr. Virgil Mihaescu | Augsburg | Germany | Unknown status |
| Dermatologie Bad Kreuznach - Dr. med. Georg Mauer | Bad Kreuznach | Germany | Unknown status |
| Praxis Dr. A. Magerl | Bensheim | Germany | Unknown status |
| Hautzentrum | Bergen | Germany | Unknown status |
| Hautzentrum Weißensee | Berlin | Germany | Unknown status |
| Dr. Christiane Handrick Hautarztpraxis | Berlin | Germany | Unknown status |
| Hautarztpraxis Dr. med. Thomas Schirmer | Berlin | Germany | Unknown status |
| Dres. Ziethen-Stavermann GbR | Berlin | Germany | Unknown status |
| Hautarztpraxis Weid | Bingen | Germany | Unknown status |
| Hautarztpraxis an der Hase Studienzentrum | Bramsche | Germany | Unknown status |
| Hautärzte Braunschweig | Braunschweig | Germany | Unknown status |
| Elbe Kliniken Stade - Buxtehude GmbH | Buxtehude | Germany | Unknown status |
| Hautarztpraxis Dr. med. Daniela Kasche | Buxtehude | Germany | Unknown status |
| Praxis Dr. Voth | Cologne | Germany | Unknown status |
| BAG Freitag und Knöll | Falkensee | Germany | Unknown status |
| Haut- und Laserzentrum Freisung Prof. Kurzen | Freising | Germany | Unknown status |
| ÜUeberoertliche Gemeinschaftspraxis Jost Kai Rietkoetter Robert Jablonka | Gelsenkirchen | Germany | Unknown status |
| Hautarztpraxis Dr. med Michael Loth | Gernsbach | Germany | Unknown status |
| Hautarztpraxis Dr. Brinkmann, Schult & Samimi-Fard | Gladbeck | Germany | Unknown status |
| Hautarztpraxis Dr. med. Matthias Lütten | Hamburg | Germany | Unknown status |
| Universitätsklinikum Hamburg-Eppendorf | Hamburg | Germany | Unknown status |
| Cutaneum Praxis Dr. Buck | Hamburg | Germany | Unknown status |
| dermaSANA | Karlsruhe | Germany | Unknown status |
| Kosmedikulm | Kulmbach | Germany | Unknown status |
| Dr. Beate Schwarz | Langenau | Germany | Unknown status |
| "Magdeburger company for Medical studies & Services" | Magdeburg | Germany | Unknown status |
| Dermatologische Gemeinschaftspraxis Dres. Quist PartG | Mainz | Germany | Unknown status |
| Dermatologie Mölln, Praxis Dr Segert | Mölln | Germany | Unknown status |
| ZENTderma, Dr. Rolf Ostendorf | Mönchengladbach | Germany | Unknown status |
| Hautarztpraxis Dorittke / Kardorff | Mönchengladbach | Germany | Unknown status |
| Praxis Dr. Quack | München | Germany | Unknown status |
| Hautarztpraxis Dr. Susanne Gißler-Walter | Mutterstadt | Germany | Unknown status |
| Dermatologische Praxis im Hautzentrum Johannis Dr. med. Esther Völkel | Nuremberg | Germany | Unknown status |
| Hautarztpraxis Mortazawi | Remscheid | Germany | Unknown status |
| Dermatologische Spezialpraxis Dr. med. Ralph von Kiedrowski | Selters | Germany | Unknown status |
| Dermatologisches Studienzentrum Hunsrück - DSH | Simmern | Germany | Unknown status |
| Hautarztpraxis Dr. Hoffmann | Witten | Germany | Unknown status |
The registry text, word for word
This page is information, not medical advice. Discuss any trial with your doctor.